| Medtronic plc | $110.5b | $95.64 | -1.2% | 4.8M | |
| Edwards Lifesciences Corp | $49.1b | $89.16 | +0.2% | 2.1M | |
| Biogen Inc. Common Stock | $32.5b | $251.12 | -1.2% | 906.3K | |
| Alcon Inc. Ordinary Shares | $30.8b | $70.17 | -0.7% | 2.5M | |
| Zimmer Biomet Holdings, Inc. | $16.8b | $98.59 | -0.3% | 1.5M | |
| Glaukos Corporation | $9.7b | $178.88 | +1.2% | 744.8K | |
| Bausch + Lomb Corporation | $6.1b | $17.00 | +0.2% | 353.3K | |
| Denali Therapeutics Inc. Common Stock | $3.2b | $18.41 | -1.4% | 93.8K | |
| Bioventus Inc. Class A Common Stock | $0.9b | $14.95 | -0.6% | 306.5K | |
| Anteris Technologies Global Corp. Common Stock | $0.8b | $5.93 | -2.3% | 744.7K | |
| BioAge Labs, Inc. Common Stock | $303.4m | $5.17 | -8.0% | 352.9K | |
| AC Immune SA | $270.9m | $2.42 | -3.6% | 136.0K | |
| Alector, Inc. Common Stock | $202.1m | $2.08 | -0.5% | 80.0K | |
| Alpha Cognition Inc. Common Stock | $198.2m | $8.36 | +0.6% | 126.3K | |
| Acumen Pharmaceuticals, Inc. Common Stock | $147.5m | $2.00 | -3.4% | 507.8K | |
| Outlook Therapeutics, Inc. Common Stock | $144.4m | $0.53 | -7.4% | 3.0M | |
| LENZ Therapeutics, Inc. Common Stock | $112.5m | $3.15 | -2.9% | 645.1K | |
| Cognition Therapeutics, Inc. Common Stock | $88.0m | $0.72 | +2.8% | 559.2K | |
| Telomir Pharmaceuticals, Inc. Common Stock | $81.2m | $1.00 | 0.0% | 46.8K | |
| Greenland Mines Ltd. Common Stock | $60.0m | $5.75 | -3.5% | 456.6K | |
| Envoy Medical, Inc. Class A Common Stock | $52.5m | $0.57 | -1.2% | 670.4K | |
| Annovis Bio, Inc. | $50.4m | $1.02 | -0.2% | 288.8K | |
| CervoMed Inc. Common Stock | $45.7m | $2.29 | +3.6% | 107.9K | |
| OSR Health, Inc. Common Stock | $15.7m | $0.11 | 0.0% | N/A | |
| FibroBiologics, Inc. Common Stock | $8.6m | $0.95 | 0.0% | 111.4K | |
| Longeveron Inc. Common Stock | $8.2m | $1.57 | -2.5% | 62.7K | |
| NeuroSense Therapeutics Ltd. Ordinary Shares | $7.5m | $2.57 | 0.0% | 10.8K | |
| Alzamend Neuro, Inc. Common Stock | $6.6m | $1.13 | +3.6% | 28.9K | |
| 20/20 Biolabs, Inc. Common Stock | $4.9m | $0.24 | -1.9% | 189.9K | |
| HCW Biologics Inc. Common Stock | $3.8m | $1.12 | 0.0% | 76.9K |